Table 2.
Pre-treatment biological characteristics of responders and non-responders.
| responders (n = 13) | non-responders (n = 24) | χ2 or ANOVA/ ANCOVAc | p < 0.05 | |
|---|---|---|---|---|
| genotype | ||||
| BCLI (GG or GC) | 10 (71%) | 7 (30%) |  |
p = 0.013 |
| glucocorticoid sensitivity | ||||
| lysozyme IC-50DEX | 3.8 ± 2.2 | 3.9 ± 1.9 | F1,30 = 0.01 | n.s. |
| glucocorticoid circadian rhythm | ||||
| bedtime cortisol | 374.3 ± 268.4 | 254.7 ± 184.2 | F1,35 = 2.57 | n.s. |
| 24 h urinary cortisola | 56.1 ± 6.8 | 60.9 ± 30.3 | F1,34 = 0.32 | n.s. |
| resilience | ||||
| DHEA/cortisol ratiob | 0.7 ± 0.1 | 0.7 ± 0.1 | F1,33 = 0.00d | n.s. |
| NPYa,b | 75.8 ± 5.6 | 58.9 ± 3.9 | F1,32 = 5.69 | p = 0.023 |
Covariates: agender, bage.
cMean ± s.d. provided for ANOVAs, and estimated marginal mean ± s.e. for ANCOVAs.
dData were substantially skewed; statistic based on analysis following natural log transformation; unlogged mean ± s.e. displayed.